C Prakash Gyawali1, Daniel Sifrim2, Dustin A Carlson3, Mary Hawn4, David A Katzka5, John E Pandolfino3, Roberto Penagini6,7, Sabine Roman8,9,10, Edoardo Savarino11, Roger Tatum12, Michel Vaezi13, John O Clarke14, George Triadafilopoulos14. 1. Division of Gastroenterology, Washington University School of Medicine, St. Louis, Missouri. 2. Barts and The London School of Medicine and Dentistry Queen Mary, University of London, London, UK. 3. Division of Gastroenterology, Department of Medicine, Northwestern University, Chicago, Illinois. 4. Department of Surgery, Stanford University, Stanford, California. 5. Division of Gastroenterology, Mayo Clinic, Rochester, Minnesota. 6. Università degli Studi di Milano, Milan, Italy. 7. Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. 8. Digestive Physiology, Hopital E Herriot, Hospices Civils de Lyon, Université de Lyon, Lyon, France. 9. Digestive Physiology, Lyon I University, Université de Lyon, Lyon, France. 10. Université de Lyon, Inserm U1032, LabTAU, Université de Lyon, Lyon, France. 11. Division of Gastroenterology, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy. 12. Department of Surgery, University of Washington, Seattle, Washington. 13. Division of Gastroenterology, Vanderbilt University, Nashville, Tennessee. 14. Division of Gastroenterology, Stanford University, Stanford, California.
Abstract
BACKGROUND: Ineffective esophageal motility (IEM) is a heterogenous minor motility disorder diagnosed when ≥50% ineffective peristaltic sequences (distal contractile integral <450 mm Hg cm s) coexist with normal lower esophageal sphincter relaxation (integrated relaxation pressure < upper limit of normal) on esophageal high-resolution manometry (HRM). Ineffective esophageal motility is not consistently related to disease states or symptoms and may be seen in asymptomatic healthy individuals. PURPOSE: A 1-day symposium of esophageal experts reviewed existing literature on IEM, and this review represents the conclusions from the symposium. Severe IEM (>70% ineffective sequences) is associated with higher esophageal reflux burden, particularly while supine, but milder variants do not progress over time or consistently impact quality of life. Ineffective esophageal motility can be further characterized using provocative maneuvers during HRM, especially multiple rapid swallows, where augmentation of smooth muscle contraction defines contraction reserve. The presence of contraction reserve may predict better prognosis, lesser reflux burden and confidence in a standard fundoplication for surgical management of reflux. Other provocative maneuvers (solid swallows, standardized test meal, rapid drink challenge) are useful to characterize bolus transit in IEM. No effective pharmacotherapy exists, and current managements target symptoms and concurrent reflux. Novel testing modalities (baseline and mucosal impedance, functional lumen imaging probe) show promise in elucidating pathophysiology and stratifying IEM phenotypes. Specific prokinetic agents targeting esophageal smooth muscle need to be developed for precision management.
BACKGROUND: Ineffective esophageal motility (IEM) is a heterogenous minor motility disorder diagnosed when ≥50% ineffective peristaltic sequences (distal contractile integral <450 mm Hg cm s) coexist with normal lower esophageal sphincter relaxation (integrated relaxation pressure < upper limit of normal) on esophageal high-resolution manometry (HRM). Ineffective esophageal motility is not consistently related to disease states or symptoms and may be seen in asymptomatic healthy individuals. PURPOSE: A 1-day symposium of esophageal experts reviewed existing literature on IEM, and this review represents the conclusions from the symposium. Severe IEM (>70% ineffective sequences) is associated with higher esophageal reflux burden, particularly while supine, but milder variants do not progress over time or consistently impact quality of life. Ineffective esophageal motility can be further characterized using provocative maneuvers during HRM, especially multiple rapid swallows, where augmentation of smooth muscle contraction defines contraction reserve. The presence of contraction reserve may predict better prognosis, lesser reflux burden and confidence in a standard fundoplication for surgical management of reflux. Other provocative maneuvers (solid swallows, standardized test meal, rapid drink challenge) are useful to characterize bolus transit in IEM. No effective pharmacotherapy exists, and current managements target symptoms and concurrent reflux. Novel testing modalities (baseline and mucosal impedance, functional lumen imaging probe) show promise in elucidating pathophysiology and stratifying IEM phenotypes. Specific prokinetic agents targeting esophageal smooth muscle need to be developed for precision management.
Authors: Sabine Roman; Zhiyue Lin; Monika A Kwiatek; John E Pandolfino; Peter J Kahrilas Journal: Am J Gastroenterol Date: 2010-10-05 Impact factor: 10.864
Authors: L Frazzoni; M Frazzoni; N de Bortoli; S Tolone; M Furnari; I Martinucci; H Bertani; S Marchi; R Conigliaro; L Fuccio; V Savarino; E Savarino Journal: Neurogastroenterol Motil Date: 2017-05-25 Impact factor: 3.598
Authors: A Mauro; E Savarino; N De Bortoli; S Tolone; D Pugliese; M Franchina; C P Gyawali; R Penagini Journal: Neurogastroenterol Motil Date: 2017-11-21 Impact factor: 3.598
Authors: P J Kahrilas; A J Bredenoord; M Fox; C P Gyawali; S Roman; A J P M Smout; J E Pandolfino Journal: Neurogastroenterol Motil Date: 2014-12-03 Impact factor: 3.598
Authors: Aleksandar P Simić; Ognjan M Skrobić; Richard R Gurski; Vladimir M Šljukić; Nenad R Ivanović; Predrag M Peško Journal: J Gastrointest Surg Date: 2014-08-05 Impact factor: 3.452
Authors: Taher I Omari; Ali Zifan; Charles Cock; Ravinder K Mittal Journal: Am J Physiol Gastrointest Liver Physiol Date: 2022-07-05 Impact factor: 4.871
Authors: Wenjun Kou; Galal Osama Galal; Matthew William Klug; Vladislav Mukhin; Dustin A Carlson; Mozziyar Etemadi; Peter J Kahrilas; John E Pandolfino Journal: Neurogastroenterol Motil Date: 2021-10-28 Impact factor: 3.960